Akili, Inc. , a leading digital medicine company, will host a conference call and webcast to review its financial and operating results for the second quarter of 2023 on Thursday, August 10, 2023, at.
DUBLIN (BUSINESS WIRE) The "Digital Therapeutics Market by Application, Type, End User - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.The global digital therapeutics market is projected to reach $42.98 billion by 2030 at a CAGR of 31.1% from 2023 to 2030.Succeeding extensive.
Akili, Inc. (NASDAQ:AKLI – Get Rating) was the target of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 303,800 shares, a decline of 23.9% from the May 15th total of 399,400 shares. Currently, 0.8% of the shares of the stock are sold short. […]
Akili Inc AKLI released EndeavorOTC, a new immersive mobile video game treatment clinically proven to improve attention and focus, specifically in adults with…
PureTech Health PLC on Wednesday said its founded entity, Akili Inc, released an attention deficit hyperactivity disorder treatment for adult patients.
The Boston-based biotechnology company said. | June 7, 2023